Ashwagandha: Cortisol, Sleep, and the 600mg Dose Threshold

Ashwagandha benefits for men center on its ability to support healthy cortisol regulation through modulation of the hypothalamic-pituitary-adrenal axis. Clinical research demonstrates that standardized root extract at 600mg daily supports cortisol reduction in chronically stressed adults, with downstream effects on sleep quality and testosterone signaling when stress has been suppressing healthy hormonal function.

TL;DR

• Ashwagandha (Withania somnifera) is a cortisol-modulating adaptogen, it supports healthy cortisol levels in chronically stressed individuals, not universal cortisol suppression.
• The 600mg daily dose of standardized root extract (typically 5% withanolides) represents the most-studied threshold in clinical research on stress, sleep, and hormonal health.
• Sleep improvements correlate with cortisol reduction, when elevated nighttime cortisol disrupts sleep architecture, ashwagandha's HPA-axis modulation supports restoration of normal sleep cycles.
• Ashwagandha does not directly increase testosterone; it removes the cortisol brake that chronic stress places on healthy testosterone signaling.
• Clinical timelines show measurable effects at 4-8 weeks of continuous daily use; 12-month safety data supports continuous daily dosing without cycling.
• Total Men's Package includes 300mg ashwagandha whole herb (5% withanolides) as part of a multi-ingredient protocol designed for daily continuous use.

What ashwagandha is and why cortisol matters

Ashwagandha (Withania somnifera) is an adaptogenic herb used in Ayurvedic medicine for more than 3,000 years. The term "adaptogen" describes plants that support the body's response to physical and psychological stress, not by stimulating or sedating universally, but by modulating stress-response systems toward homeostasis.

The primary mechanism of interest for men 35-55 is ashwagandha's effect on the hypothalamic-pituitary-adrenal axis, the HPA axis. This system governs cortisol secretion. Cortisol is not inherently harmful; it is a necessary hormone for waking, immune function, and metabolic regulation. The problem arises when chronic stress keeps cortisol elevated outside normal circadian patterns.

Elevated cortisol has three direct effects relevant to men seeking to optimize hormonal function:

First: Cortisol competes with testosterone at the cellular level. Both hormones are synthesized from the same precursor, pregnenolone, in the adrenal glands and gonads. When the body prioritizes cortisol production in response to chronic stress, testosterone synthesis receives fewer resources. This is not hypothetical; it is a documented metabolic trade-off in steroidogenesis.

Second: Elevated nighttime cortisol disrupts sleep architecture. Cortisol should decline in the evening to allow melatonin to rise and initiate sleep. When cortisol remains elevated, sleep onset is delayed, slow-wave sleep is reduced, and fragmented sleep becomes the norm. Poor sleep, in turn, suppresses testosterone signaling and impairs recovery.

Third: Chronic cortisol elevation increases visceral adiposity (belly fat). Adipose tissue in the abdomen contains the enzyme aromatase, which converts testosterone to estradiol. More belly fat means more aromatase activity, which means more testosterone conversion to estrogen, a compounding negative feedback loop.

Ashwagandha's documented benefit is in modulating the HPA axis to reduce cortisol when it is chronically elevated, not in suppressing cortisol universally. This distinction matters. Men who are not chronically stressed do not see the same magnitude of benefit because there is no cortisol dysregulation to correct.

The 600mg dose threshold and why standardization matters

Most clinical research on ashwagandha uses standardized root extract at 600mg per day, typically split into two 300mg doses. Standardization refers to the concentration of withanolides, the bioactive compounds in ashwagandha, expressed as a percentage. Most studies use extracts standardized to 5% withanolides, meaning 600mg of extract delivers 30mg of withanolides.

The 600mg threshold appears repeatedly in the literature because it was the dose used in the foundational studies on cortisol and stress. Chandrasekhar et al. 2012 conducted a randomized, double-blind, placebo-controlled trial on 64 adults with chronic stress. The treatment group received 300mg of ashwagandha root extract twice daily for 60 days. Serum cortisol decreased by 27.9% in the ashwagandha group compared to baseline. The placebo group showed no significant change.

A 2019 study by Lopresti et al. replicated these findings in 60 adults with self-reported stress. The ashwagandha group (240mg daily for 60 days) showed significant reductions in cortisol, improved sleep quality scores, and reduced stress markers compared to placebo. This study used a lower dose, 240mg daily, but the extract was concentrated to 35% withanolides, delivering a similar withanolide load to the 600mg 5%-standardized dose.

The key takeaway: the withanolide content matters more than the total milligram dose of raw herb. A 300mg dose of 5% withanolide extract is not equivalent to 300mg of whole herb or unstandardized powder. This is why Brookhaven specifies the standardization level on the label, 300mg ashwagandha whole herb at 5% withanolides in Total Men's Package.

KSM-66 vs Sensoril: root vs root-and-leaf extracts

Two proprietary ashwagandha extracts dominate the research literature: KSM-66 and Sensoril. Understanding the difference helps contextualize study results and product claims.

KSM-66 is a full-spectrum extract made exclusively from ashwagandha root. It is standardized to 5% withanolides and uses a solvent-free extraction process. Most studies on cortisol, stress, and testosterone signaling use KSM-66 at 600mg daily. The research base is extensive, more than 20 published human trials as of 2025.

Sensoril is an extract made from both root and leaf. It is standardized to higher withanolide concentrations (typically 8-10%) but also contains withaferin A, a compound found primarily in the leaves. Withaferin A has demonstrated cytotoxic effects in cell cultures at high concentrations, which has raised questions about long-term safety of leaf-inclusive extracts. Sensoril studies typically use lower total doses (125-250mg daily) because of the higher withanolide concentration.

The clinical evidence for cortisol reduction and sleep improvement is stronger for root-only extracts at the 600mg dose. Leaf-inclusive extracts may offer benefits, but the withaferin A content requires more safety data before recommending long-term daily use. Brookhaven uses ashwagandha whole herb, which means the root, at the 5% withanolide standardization level aligned with the published research on men's health outcomes.

Ashwagandha and sleep: the cortisol-melatonin relationship

Sleep quality improvements in ashwagandha studies correlate directly with cortisol reduction. This is not coincidental. The circadian rhythm of cortisol secretion is tightly linked to the sleep-wake cycle.

Under normal conditions, cortisol peaks in the early morning (the cortisol awakening response) and declines throughout the day, reaching its lowest point in the late evening. This decline allows melatonin, the sleep-initiating hormone, to rise and signal the onset of sleep. When chronic stress keeps cortisol elevated in the evening, melatonin secretion is blunted, sleep onset is delayed, and time spent in restorative slow-wave sleep decreases.

Studies show that ashwagandha supports sleep quality by restoring the normal cortisol decline. Lopresti et al. 2019 found that overweight men aged 40-70 taking 600mg ashwagandha daily for 8 weeks reported significant improvements in sleep quality scores and reductions in fatigue compared to placebo. Serum cortisol and DHEA-S levels also improved in the treatment group.

The mechanism is not sedation, ashwagandha does not act like a GABAergic sleep aid. Instead, it supports the restoration of circadian cortisol patterns, which allows the natural sleep-wake cycle to function without chronic stress interference. For men experiencing sleep disruption driven by elevated nighttime cortisol, often manifesting as difficulty falling asleep or waking between 2-4 AM, ashwagandha addresses the upstream cause rather than masking the symptom.

Timing matters. Most studies dose ashwagandha twice daily, morning and evening. For men prioritizing sleep quality, an evening dose is logical. The goal is to support the natural cortisol decline that should occur in the hours before bed. Brookhaven recommends taking Total Men's Package in the morning with food, but men experiencing evening cortisol symptoms may benefit from splitting the dose, 4 capsules in the morning, 3 in the evening, though this is an individual optimization decision, not a requirement.

The testosterone connection: removing the cortisol brake

Ashwagandha does not increase testosterone in a direct, pharmacological sense. It is not an exogenous androgen. It does not stimulate Leydig cells to produce more testosterone. The relationship between ashwagandha and testosterone is indirect and conditional: when chronic stress is suppressing testosterone signaling through elevated cortisol, ashwagandha supports the restoration of healthy signaling by reducing that cortisol burden.

The evidence for this comes from studies on chronically stressed or overweight men, populations where cortisol dysregulation is common. Lopresti et al. 2019 found that overweight men aged 40-70 taking 600mg ashwagandha daily showed a 14.7% increase in total testosterone and an 18% increase in DHEA-S after 8 weeks compared to placebo. The study also showed reductions in cortisol and improvements in vitality and sexual function scores.

These results are meaningful, but they must be contextualized. The men in this study were overweight with elevated stress markers, a population where cortisol suppression of testosterone signaling is likely. The testosterone increase reflects the removal of a suppressive factor, not the addition of a stimulatory one. Men with low cortisol or no chronic stress would not see the same magnitude of effect.

This is why Brookhaven frames ashwagandha as part of a comprehensive protocol, not a standalone testosterone optimizer. The Foundation approach addresses testosterone signaling through multiple pathways: nutrient density (beef organs), direct precursor support (zinc, magnesium, boron), cortisol modulation (ashwagandha), and bioavailability enhancement (shilajit). Each ingredient addresses a different bottleneck. Ashwagandha handles the stress bottleneck.

Clinical timeline: when to expect results

Ashwagandha is not an acute-effect supplement. The HPA axis modulation that drives cortisol reduction takes weeks to manifest. Most clinical trials measure outcomes at 8 weeks, though some show measurable effects at 4 weeks.

The timeline for specific outcomes varies:

Cortisol reduction: 4-8 weeks of daily use. Serum cortisol measurements in studies show statistically significant reductions by week 8, with trends emerging at week 4.

Sleep quality improvements: 6-8 weeks. Subjective sleep quality scores improve as cortisol patterns normalize. Men report easier sleep onset, fewer nighttime awakenings, and better morning alertness.

Stress and vitality scores: 8 weeks. Psychological stress assessments and vitality questionnaires show improvements at the 8-week mark in most studies.

Testosterone signaling support: 8-12 weeks. The indirect effect on testosterone, mediated by cortisol reduction, takes the longest to manifest because it requires sustained normalization of the HPA axis.

Brookhaven recommends evaluating results after 90 days of continuous daily use. This is not a cycle, it is the onboarding window before the protocol becomes routine for life. The compounding effect of daily use is the goal, not short-term supplementation.

Safety profile and who should not take ashwagandha

Ashwagandha's safety profile at standardized doses is well-documented. Salve et al. 2025 published 12-month safety data on ashwagandha root extract standardized to 5% withanolides at doses up to 600mg daily. The study found no clinically significant adverse effects on liver enzymes, kidney function, hematological markers, or thyroid function in healthy adults taking the extract continuously for one year.

Short-term studies report mild gastrointestinal upset in a small percentage of users, typically resolved by taking ashwagandha with food. No serious adverse events have been reported in published clinical trials using standardized root extract at recommended doses.

That said, specific populations should avoid ashwagandha or consult a physician before use:

Thyroid medication users: Ashwagandha may influence thyroid hormone levels. Some studies show increases in T4 in individuals with subclinical hypothyroidism. Men taking levothyroxine or other thyroid medications should monitor thyroid function with their physician if adding ashwagandha.

Pregnant or breastfeeding women: Safety data in pregnancy is insufficient. Traditional Ayurvedic texts suggest avoiding ashwagandha during pregnancy due to potential effects on uterine tone.

Autoimmune disease patients: Ashwagandha's immune-modulating effects may theoretically exacerbate autoimmune conditions, though clinical evidence is limited. Men with autoimmune diagnoses should consult their physician.

Pre-surgical patients: Ashwagandha may have mild sedative effects and could theoretically interact with anesthesia. Discontinue use 2 weeks before scheduled surgery.

No cycling is required. The 12-month safety data supports continuous daily use at standardized doses. The mechanism of action, HPA axis modulation, does not cause tolerance or downregulation that would necessitate time off.

How ashwagandha fits in the Brookhaven approach

Ashwagandha in Total Men's Package is dosed at 300mg whole herb standardized to 5% withanolides, 15mg of withanolides per serving. This is half the 600mg dose used in most clinical studies, and that is intentional.

The Brookhaven protocol is built on multi-ingredient synergy, not single-ingredient mega-dosing. Ashwagandha handles cortisol modulation. Tongkat ali supports testosterone signaling through free testosterone optimization. Shilajit enhances bioavailability and mitochondrial function. Fenugreek supports glucose metabolism and body composition. Beef organs deliver micronutrient density. Minerals (zinc, magnesium, boron) provide the raw materials for testosterone synthesis. The stack works because each ingredient addresses a different physiological bottleneck.

The 300mg dose of ashwagandha is not a compromise, it is a deliberate design choice. Studies show that lower doses in multi-ingredient protocols can achieve outcomes comparable to higher doses of isolated ingredients. Smith et al. 2023 demonstrated that a multi-herb adaptogenic blend including ashwagandha at 200mg daily produced significant stress and cortisol reductions, suggesting that synergistic formulations allow for effective dosing below the monotherapy threshold.

The goal is daily continuous use for life. The formulation is designed to be sustainable, no cycling, no loading phases, no breaks. Men who follow the protocol see compounding benefits over months and years, not just weeks. Ashwagandha is one lever in a system built to support long-term hormonal health, not a short-term cortisol fix.

For men 35-55 facing chronic stress, poor sleep, and the downstream hormonal effects of elevated cortisol, ashwagandha is a research-backed tool. It does not replace stress management, sleep hygiene, or strength training. It supports the body's ability to regulate the HPA axis when chronic stress has disrupted normal cortisol patterns. That is the mechanism. That is the benefit. That is why it is in the formulation.

Frequently asked questions

Does ashwagandha support testosterone signaling in men?

Yes, but indirectly. Ashwagandha does not stimulate testosterone production directly. It supports testosterone signaling by reducing elevated cortisol in chronically stressed men. Cortisol competes with testosterone for synthesis resources and suppresses healthy signaling. Studies on overweight or stressed men show testosterone increases of 10-18% after 8-12 weeks of ashwagandha use at 600mg daily, correlated with cortisol reduction. Men without elevated cortisol or chronic stress see smaller effects. Ashwagandha removes the cortisol brake on testosterone, it does not add exogenous hormones or directly stimulate Leydig cells.

How long does it take to see results from ashwagandha?

Measurable cortisol reduction occurs at 4-8 weeks of daily use. Sleep quality improvements typically appear at 6-8 weeks as cortisol patterns normalize. Stress and vitality scores improve by week 8 in clinical trials. Downstream effects on testosterone signaling take 8-12 weeks because they require sustained HPA axis normalization. Brookhaven recommends evaluating results after 90 days of continuous daily use. This is not a cycle or trial period, it is the onboarding window before the protocol becomes routine for life. The compounding effect of daily use is the goal.

Should I take ashwagandha in the morning or evening?

Most clinical studies dose ashwagandha twice daily, morning and evening. For men prioritizing sleep quality, an evening dose is logical because it supports the natural cortisol decline that occurs in the hours before bed. Elevated nighttime cortisol delays sleep onset and reduces slow-wave sleep; ashwagandha's cortisol-modulating effect helps restore normal circadian patterns. Brookhaven recommends taking Total Men's Package in the morning with food as the default, but men experiencing evening cortisol symptoms (difficulty falling asleep, waking between 2-4 AM) may benefit from splitting the dose, 4 capsules morning, 3 evening. This is individual optimization, not a requirement.

Is ashwagandha safe for long-term daily use?

Yes. A 12-month safety study on ashwagandha root extract standardized to 5% withanolides at 600mg daily found no clinically significant adverse effects on liver enzymes, kidney function, hematological markers, or thyroid function in healthy adults. Short-term studies report mild gastrointestinal upset in a small percentage of users, typically resolved by taking ashwagandha with food. No cycling is required, the mechanism of action (HPA axis modulation) does not cause tolerance or downregulation. Brookhaven formulates Total Men's Package for daily continuous use for life. Men on thyroid medication, pregnant women, and individuals with autoimmune conditions should consult a physician before use.

What is the difference between KSM-66 and Sensoril ashwagandha?

KSM-66 is a full-spectrum extract made exclusively from ashwagandha root, standardized to 5% withanolides, using a solvent-free extraction process. Most clinical research on cortisol, stress, and testosterone signaling uses KSM-66 at 600mg daily. Sensoril is an extract made from both root and leaf, standardized to higher withanolide concentrations (8-10%) but also containing withaferin A, a compound found primarily in the leaves. Withaferin A has demonstrated cytotoxic effects in cell cultures at high concentrations, raising questions about long-term safety of leaf-inclusive extracts. The evidence base for cortisol reduction and sleep improvement is stronger for root-only extracts. Brookhaven uses ashwagandha whole herb (root) at 5% withanolide standardization aligned with the published research on men's health outcomes.

Can ashwagandha help with sleep if I do not have high cortisol?

Ashwagandha's primary mechanism for sleep improvement is restoring circadian cortisol patterns, it supports the natural cortisol decline that occurs in the evening to allow melatonin to rise. Men with normal cortisol patterns may see minimal direct sleep benefit from ashwagandha alone because there is no cortisol dysregulation to correct. That said, ashwagandha's stress-buffering effects may still improve subjective sleep quality through reduced psychological arousal. It is not a sedative, it does not act like a GABAergic sleep aid. If poor sleep is driven by elevated nighttime cortisol (difficulty falling asleep, waking between 2-4 AM), ashwagandha addresses the upstream cause. If poor sleep is driven by other factors (sleep apnea, circadian misalignment, poor sleep hygiene), ashwagandha is unlikely to be the solution.

Does ashwagandha interact with other supplements or medications?

Ashwagandha may influence thyroid hormone levels, so men taking levothyroxine or other thyroid medications should monitor thyroid function with their physician if adding ashwagandha. It may have mild sedative effects and could theoretically interact with anesthesia, discontinue use 2 weeks before scheduled surgery. There are no documented interactions with the other ingredients in Total Men's Package (tongkat ali, shilajit, fenugreek, beef organs, minerals). Ashwagandha's cortisol-modulating effect is complementary to the testosterone-signaling support from tongkat ali and the bioavailability enhancement from shilajit. No cycling or time off is required. The formulation is designed for daily continuous use without interactions or tolerance buildup.

Why does Total Men's Package include 300mg ashwagandha instead of the 600mg dose used in studies?

The 300mg dose in Total Men's Package is a deliberate design choice based on multi-ingredient synergy, not a compromise. Most clinical studies dose ashwagandha in isolation at 600mg daily. The Brookhaven protocol stacks ashwagandha with tongkat ali, shilajit, fenugreek, beef organs, and targeted minerals, each addressing a different physiological bottleneck. Research on multi-herb adaptogenic blends shows that lower doses of individual ingredients in synergistic formulations can achieve outcomes comparable to higher doses of isolated ingredients. The 300mg dose of ashwagandha at 5% withanolides delivers 15mg of withanolides per serving, which is sufficient for cortisol modulation when combined with the other components of the stack. The goal is sustainable daily continuous use for life, not mega-dosing a single ingredient.

Sources

• Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. 2012;34(3):255-262.
• Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine. 2019;98(37):e17186.
• Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males. American Journal of Men's Health. 2019;13(2):1557988319835985.
• Smith SJ, Lopresti AL, Teo SYM, Fairchild TJ. Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology. 2023;37(12):1091-1104.
• Salve J, Lopresti A, Pase M, Langade D. Safety of 12-Months Administration of Ashwagandha Standardized Root Extract in Healthy Adults. Phytotherapy Research. 2025;39(1):196-208.
• National Institutes of Health Office of Dietary Supplements. Dietary Supplements: What You Need to Know.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.